Affiliate disclosure: Care Path Compare maintains commercial partnerships with telehealth providers including Wellmedr and Gala Health. When you click through our links to enroll, we may receive compensation at zero extra cost to you. Dosing schedules and conversion math are compiled strictly from FDA clinical labeling and USP compounding standards.
The standard tirzepatide titration schedule (2.5 mg to 15.0 mg)
Tirzepatide is a dual GLP-1 and GIP receptor agonist. Because incretin mimetics significantly slow gastric emptying and alter gastrointestinal motility, gradual titration is clinically mandatory. Skipping titration steps or escalating prematurely causes severe nausea, vomiting, dehydration, and gastrointestinal distress.
| Stage | Weekly Dose | Recommended Duration | Primary Clinical Purpose | Therapeutic Goal |
|---|---|---|---|---|
| Step 1 (Starter) | 2.5 mg | Weeks 1–4 (4 weeks) | Treatment initiation & tolerability assessment | Acclimate gut peptides; not considered a primary therapeutic dose |
| Step 2 (Low Therapeutic) | 5.0 mg | Weeks 5–8 (4 weeks) | First clinically effective therapeutic dose | Noticeable appetite suppression and early weight loss |
| Step 3 (Intermediate) | 7.5 mg | Weeks 9–12 (optional / 4 weeks) | Incremental glycemic & metabolic titration | Escalation step if 5.0 mg weight loss slows |
| Step 4 (Maintenance) | 10.0 mg | Weeks 13–16 (4 weeks or ongoing) | Standard clinical maintenance dose | Robust sustained weight loss in landmark clinical trials |
| Step 5 (Advanced) | 12.5 mg | Weeks 17–20 (optional / 4 weeks) | Advanced metabolic titration step | Reserved for patients needing additional glycemic or satiety control |
| Step 6 (Maximum) | 15.0 mg | Weeks 21+ (ongoing maintenance) | Maximum approved clinical dose | Peak efficacy observed in SURMOUNT clinical trials (~20.9% weight loss) |
Clinical Note: You do not need to escalate to 15.0 mg if you achieve steady, satisfying weight reduction (1 to 2 lbs per week) and good glycemic control on 5.0 mg or 10.0 mg. Always consult your prescribing clinician before adjusting dosage.
Milligrams vs. Syringe Units: How concentration changes your dose
The single most common dosing mistake with compounded GLP-1 medications occurs when patients confuse milligrams (mg) with syringe units.
- Milligrams (mg): The weight or mass of the active tirzepatide peptide molecule prescribed by your doctor (e.g., 2.5 mg).
- Units: The volumetric measurement mark on an insulin syringe (e.g., 25 units).
- Concentration (mg/mL): The amount of tirzepatide dissolved in each milliliter of liquid inside your vial.
Because different 503A compounding pharmacies formulate tirzepatide at different concentrations, 2.5 mg does not equal the same number of units across all vials. Always inspect the concentration printed on your vial label before drawing medication.
Dosage Conversion Table 1: 10 mg/mL Concentration Vials
In a 10 mg/mL vial, every 1.0 mL of liquid contains 10 milligrams of tirzepatide. On a standard U-100 syringe (100 units = 1.0 mL), each unit equals 0.1 mg.
| Target Weekly Dose (mg) | Volume Needed (mL) | Syringe Mark (Units on U-100 Syringe) | Common Titration Step |
|---|---|---|---|
| 2.5 mg | 0.25 mL | 25 units | Initiation (Weeks 1–4) |
| 5.0 mg | 0.50 mL | 50 units | Step 2 (Weeks 5–8) |
| 7.5 mg | 0.75 mL | 75 units | Step 3 (Weeks 9–12) |
| 10.0 mg | 1.00 mL | 100 units (full syringe) | Step 4 (Weeks 13–16) |
Notice: At doses above 10.0 mg, a 10 mg/mL vial requires injecting more than 1.0 mL of volume, which is why pharmacies switch to a 20 mg/mL concentration for higher maintenance doses.
Dosage Conversion Table 2: 20 mg/mL Concentration Vials
In a 20 mg/mL vial, the liquid is twice as concentrated. Every 1.0 mL contains 20 milligrams of tirzepatide, meaning you inject half the liquid volume for the same active dose.
| Target Weekly Dose (mg) | Volume Needed (mL) | Syringe Mark (Units on U-100 Syringe) | Common Titration Step |
|---|---|---|---|
| 2.5 mg | 0.125 mL | 12.5 units | Initiation (Weeks 1–4) |
| 5.0 mg | 0.25 mL | 25 units | Step 2 (Weeks 5–8) |
| 7.5 mg | 0.375 mL | 37.5 units | Step 3 (Weeks 9–12) |
| 10.0 mg | 0.50 mL | 50 units | Step 4 (Weeks 13–16) |
| 12.5 mg | 0.625 mL | 62.5 units | Step 5 (Weeks 17–20) |
| 15.0 mg | 0.75 mL | 75 units | Maximum Dose (Weeks 21+) |
[!WARNING] Check your vial label every single refill! Compounding pharmacies often change vial concentrations as your prescription titrates upward (e.g., shipping a 10 mg/mL vial for Month 1 and a 20 mg/mL vial for Month 3). If your concentration doubles from 10 mg/mL to 20 mg/mL and you continue drawing 50 units, you will accidentally inject 10 mg instead of 5 mg, causing severe gastrointestinal toxicity. Always check the
mg/mLrating on every new prescription box.
How to draw and inject compounded tirzepatide safely
Follow these standard aseptic clinical procedures for every weekly injection:
- Clean Your Work Area: Wash your hands thoroughly with soap and warm water for at least 20 seconds.
- Disinfect the Vial Stopper: Wipe the rubber stopper on top of the tirzepatide vial with a fresh 70% isopropyl alcohol swab and allow it to air-dry for 10 seconds. Never touch the rubber stopper with your fingers after cleaning.
- Draw Air into the Syringe: Pull back the syringe plunger to draw in air equal to your intended dose volume (e.g., 25 units of air for a 25-unit dose).
- Equalize Vial Pressure: Invert the vial, insert the needle straight through the center of the rubber stopper, and push the plunger down to inject the air into the vial. This prevents a vacuum from forming inside the vial.
- Draw the Medication: With the vial still inverted, slowly pull back the plunger until the tip of the black plunger seal aligns exactly with your prescribed unit mark. Check for large air bubbles; tap the syringe barrel gently to move bubbles to the top and push them back into the vial.
- Select Injection Site: Choose a clean subcutaneous injection site: the abdomen (at least 2 inches away from the navel), the front of the middle thigh, or the back of the upper arm. Rotate your injection site each week.
- Subcutaneous Administration: Clean the skin site with an alcohol swab. Pinch a 1-to-2-inch fold of skin, insert the needle at a 90-degree angle (or 45 degrees if very lean), and smoothly depress the plunger. Hold the needle in place for 5 seconds before withdrawing to prevent medication seepage. Dispose of the syringe immediately in an FDA-cleared sharps container.
Economic impact: Flat-rate vs. dose-escalation pricing models
As your tirzepatide dose increases from 2.5 mg to 15.0 mg, the economic structure of your telehealth provider becomes the single largest determinant of your total out-of-pocket healthcare expenses.
The Dose-Escalation Trap
Many online clinics advertise tirzepatide starting at $249 to $299 per month. However, their fine print reveals that this price only covers starter doses (2.5 mg and 5.0 mg). Once you reach 7.5 mg or 10.0 mg, monthly prices escalate to $379 to $429/month. At 12.5 mg and 15.0 mg, prices jump to $499 to $599+ per month, doubling your monthly outlay.
Flat-Rate Telehealth Programs
Flat-rate programs charge the same monthly price regardless of whether you inject 2.5 mg or 15.0 mg:
- Wellmedr: Offers a promotional introductory rate of $89 for Month 1, then renews at a flat $329/month across all dosage tiers up to 15.0 mg with zero membership fees.
- OrderlyMeds: Charges a true flat $299/month across all dosage tiers from 2.5 mg to 15.0 mg with month-to-month billing.
- Gala Health: Packages compounded tirzepatide into multi-month bundles starting at $299/month equivalent ($897 billed upfront for 3 months) with flat pricing across maintenance tiers.
Cumulative 6-Month Cost Comparison by Dosing Escalation
The table below contrasts what a patient pays over a standard 6-month titration course (Months 1–2 on 2.5–5mg, Months 3–4 on 7.5–10mg, Months 5–6 on 12.5–15mg):
| Pricing Architecture | Month 1 (2.5mg) | Month 2 (5.0mg) | Month 3 (7.5mg) | Month 4 (10mg) | Month 5 (12.5mg) | Month 6 (15mg) | Total 6-Month Outlay |
|---|---|---|---|---|---|---|---|
| Dose-Tiered Clinic | $249 | $299 | $399 | $399 | $499 | $499 | $2,344 total |
| Henry Meds | $397 | $397 | $449 | $449 | $449 | $449 | $2,590 total |
| OrderlyMeds (Flat) | $299 | $299 | $299 | $299 | $299 | $299 | $1,794 total (saves $550–$796) |
| Wellmedr (Flat Promo) | $89 | $329 | $329 | $329 | $329 | $329 | $1,734 total (saves $610–$856) |
| Gala Health (Bundles) | $299/mo | $299/mo | $299/mo | $299/mo | $299/mo | $299/mo | $1,794 total (saves $550–$796) |
Conclusion: Choosing a flat-rate provider like Wellmedr, Gala Health, or OrderlyMeds saves between $550 and $850+ within your first six months of tirzepatide treatment.
Managing side effects during dose titration
Mild to moderate gastrointestinal side effects are common during dose escalation. Clinical strategies to manage symptoms include:
- Eat Smaller, Frequent Meals: Slower stomach emptying means large meals trigger immediate bloating, nausea, and reflux. Divide your daily food intake into four or five smaller meals.
- Prioritize Dietary Protein: Aim for 20 to 30 grams of lean protein per meal to preserve lean muscle mass during active weight loss.
- Avoid High-Fat and Fried Foods: High-fat meals drastically delay gastric transit time, significantly worsening nausea and diarrhea.
- Stay Hydrated: Drink at least 64 to 80 ounces of water daily. Consider electrolyte supplements if experiencing nausea or mild diarrhea.
- Do Not Hesitate to Pause Escalation: If you experience uncomfortable nausea when moving to a higher dose, contact your prescribing clinician. Remaining at your current dose for an additional 2 to 4 weeks allows your gastrointestinal tract to acclimate before attempting escalation again.
Missed tirzepatide dose rules
If you forget or miss a weekly injection:
- Within 4 Days (96 Hours): Administer the missed dose immediately, then resume your regular injection schedule with at least 72 hours between doses.
- More Than 4 Days: Skip the missed dose entirely and resume on your next scheduled injection day. Never inject a double dose.
- Missed 2+ Weeks (14+ Days): Do not re-inject your high maintenance dose due to rapid loss of gastrointestinal tolerance. Review our GLP-1 missed dose and titration resumption guide for physician restart protocols.